Affordable Access

A nitroimidazole derivative, PR-350, enhances the killing of pancreatic cancer cells exposed to high-dose irradiation under hypoxia.

Authors
Type
Published Article
Journal
Journal of radiation research
Publication Date
Volume
43
Issue
1
Pages
43–51
Identifiers
PMID: 12056329
Source
Medline

Abstract

Statistics

Seen <100 times